China Tianying: the subsidiary signed a strategic cooperation agreement with PowerChina hydropower

EqualOcean Releases the 'EqualOcean 2025 GoGlobal Service Enablers TOP 50'

EqualOcean released the "EqualOcean 2025 GoGlobal Service Enablers TOP 50", selecting 50 representative companies across different segments and sectors, to record and pay tribute to their contributions in advancing the globalization of Chinese enterprises.

Mabwell Signs GCC Licensing Deal with Saudi Arabia’s SVAX for Aflibercept Biosimilar

Mabwell (Shanghai) Bioscience Co., Ltd.（迈威（上海）生物科技股份有限公司）has entered into a licensing agreement with Saudi Arabian biopharmaceutical company SVAX Inc. covering its aflibercept biosimilar, 9MW0813, in the Gulf Cooperation Council market.

Insilico Medicine (英矽智能) Signs Strategic Drug Discovery Partnership with Takeda (武田制药), Deal Worth Up to US$600 Million

Chinese AI drug discovery company Insilico Medicine (英矽智能) has signed a global strategic collaboration with Japanese pharmaceutical company Takeda (武田制药), with the total potential deal value reaching up to US$600 million. Announced in early July, the agreement marks another milestone in the international commercialization of China's AI-powered drug discovery technologies through collaboration with a leading multinational pharmaceutical company.

Drug Farm Raises $55 Million in First Closing of Series D Financing

According to EO (亿欧), Drug Farm (药物牧场) announced on July 13 that it had raised $55 million in the first closing of its Series D financing round.

China Unicom to Step Down from NYSE in October

The action took effect in May this year after the board of directors decided to terminate the ADR, later issuing a notice to the ADR agency BNY Mellon.